Delayed administration of a single dose of lithium promotes recovery from AKI

Journal of the American Society of Nephrology

Volumn 25, Issue 3, 2014, Pages 488-500

  Bao, Hui ^a,b   Ge, Yan ^b   Wang, Zhen ^a,b   Zhuang, Shougang ^b   Dworkin, Lance ^b   Peng, Ai ^a   Gong, Rujun ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CISPLATIN; CREATININE; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LITHIUM; MYC PROTEIN;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL POPULATION; CELL PROLIFERATION; COLON CANCER; COMPUTER MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; HUMAN; INFANT; KIDNEY CELL CULTURE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; SINGLE DRUG DOSE; THERAPY DELAY; TISSUE REPAIR; UPREGULATION;

ACUTE KIDNEY INJURY; ANIMALS; ANTIMANIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DISEASE MODELS, ANIMAL; GLYCOGEN SYNTHASE KINASE 3; KIDNEY TUBULES; LITHIUM; MALE; MICE; REGENERATION; REPERFUSION INJURY;

EID: 84896836596     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013040350     Document Type: Article

References (52)

1. Murugan R, Kellum JA: Acute kidney injury: What's the prognosis? Nat Rev Nephrol 7: 209-217, 2011
2. Humphreys BD, Czerniak S, DiRocco DP, Hasnain W, Cheema R, Bonventre JV: Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci U S A 108: 9226-9231, 2011
3. Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS, McMahon AP, Bonventre JV: Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2: 284-291, 2008 (Pubitemid 351298594)
4. Witzgall R, Brown D, Schwarz C, Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93: 2175-2188, 1994
5. Yang L, Humphreys BD, Bonventre JV: Pathophysiology of acute kidney injury to chronic kidney disease: Maladaptive repair. Contrib Nephrol 174: 149-155, 2011
6. Rayasam GV, Tulasi VK, Sodhi R, Davis JA, Ray A: Glycogen synthase kinase 3: More than a namesake. Br J Pharmacol 156: 885-898, 2009
7. Cohen P, Frame S: The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769-776, 2001 (Pubitemid 33679839)
8. Nelson PJ, Cantley L: GSK3beta plays dirty in acute kidney injury. J Am Soc Nephrol 21: 199-200, 2010
9. Bao H, Ge Y, Zhuang SG, Dworkin LD, Liu ZH, Gong R: Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury. Kidney Int 81: 662-673, 2012
10. Baldessarini RJ, Tondo L, Hennen J: Lithium treatment and suicide risk in major affective disorders: Update and new findings. J Clin Psychiatry 64[Suppl 5]: 44-52, 2003 (Pubitemid 36539131)
11. Meijer L, Flajolet M, Greengard P: Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci 25: 471-480, 2004 (Pubitemid 39149703)
12. Vieweg WV, Yank GR, Rowe WT, Hovermale LS, Clayton AH: Increase in white blood cell count and serum sodium level following the addition of lithiumto carbamazepine treatment among three chronically psychotic male patients with disturbed affective states. Psychiatr Q 58: 213-217, 1986-1987 (Pubitemid 17123752)
13. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK: Lithium-induced increase in human brain grey matter. Lancet 356: 1241-1242, 2000
14. Yan XB, Wang SS, Hou HL, Ji R, Zhou JN: Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia. Behav Brain Res 177: 282-289, 2007 (Pubitemid 46149907)
15. Xu J, Culman J, Blume A, Brecht S, Gohlke P: Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke 34: 1287-1292, 2003 (Pubitemid 36547530)
16. Arany I, Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol 23: 460-464, 2003 (Pubitemid 37176691)
17. Yasuda H, Yuen PST, Hu X, Zhou H, Star RA: Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 69: 1535-1542, 2006
18. Sutton TA, Fisher CJ, Molitoris BA: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62: 1539-1549, 2002 (Pubitemid 35286261)
19. Mottet D, Dumont V, Deccache Y, Demazy C, Ninane N, Raes M, Michiels C: Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. J Biol Chem 278: 31277-31285, 2003 (Pubitemid 36994645)
20. Weidemann A, Bernhardt WM, Klanke B, Daniel C, Buchholz B, Câmpean V, Amann K, Warnecke C, Wiesener MS, Eckardt KU, Willam C: HIF activation protects from acute kidney injury. J Am Soc Nephrol 19: 486-494, 2008 (Pubitemid 351355392)
21. Alao JP: The regulation of cyclin D1 degradation: Roles in cancer development and the potential for therapeutic invention. Mol Cancer 6: 24, 2007
22. Gregory MA, Hann SR: c-Myc proteolysis by the ubiquitin-proteasome pathway: Stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol 20: 2423-2435, 2000 (Pubitemid 30152050)
23. Yee Koh M, Spivak-Kroizman TR, Powis G: HIF-1 regulation: Not so easy come, easy go. Trends Biochem Sci 33: 526-534, 2008
24. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG; University of Toronto Acute Kidney Injury Research Group: Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302: 1179-1185, 2009
25. Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK: Acute kidney injury: A springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 298: F1078-F1094, 2010
26. Schmitt R, Coca S, Kanbay M, Tinetti ME, Cantley LG, Parikh CR: Recovery of kidney function after acute kidney injury in the elderly: A systematic review and meta-analysis. Am J Kidney Dis 52: 262-271, 2008 (Pubitemid 351978133)
27. Diehl JA, Cheng MG, Roussel MF, Sherr CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511, 1998 (Pubitemid 28553242)
28. Gregory MA, Qi Y, Hann SR: Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 278: 51606-51612, 2003 (Pubitemid 38020405)
29. Flügel D, Görlach A, Michiels C, Kietzmann T: Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner. Mol Cell Biol 27: 3253-3265, 2007 (Pubitemid 46685205)
30. Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman BE: The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A 101: 9085-9090, 2004 (Pubitemid 38781615)
31. Peng J, Dong Z: Role changes of β-catenin in kidney injury and repair. Kidney Int 82: 509-511, 2012
32. Peng J, Ramesh G, Sun L, Dong Z: Impaired wound healing in hypoxic renal tubular cells: Roles of hypoxia-inducible factor-1 and glycogen synthase kinase 3β/β-catenin signaling. J Pharmacol Exp Ther 340: 176-184, 2012
33. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR: Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stemcell lines. Dev Cell 12: 957-971, 2007 (Pubitemid 46805920)
34. Bendz H, Schön S, Attman PO, Aurell M: Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 77: 219-224, 2010
35. Min WW, Yuskaitis CJ, Yan Q, Sikorski C, Chen S, Jope RS, Bauchwitz RP: Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential. Neuropharmacology 56: 463-472, 2009
36. Wang Z, Havasi A, Gall J, Bonegio R, Li Z, Mao H, Schwartz JH, Borkan SC: GSK3beta promotes apoptosis after renal ischemic injury. J Am Soc Nephrol 21: 284-294, 2010
37. Phiel CJ, Wilson CA, Lee VM, Klein PS: GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423: 435-439, 2003 (Pubitemid 36626994)
38. Lyoo IK, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL, Renshaw PF: Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: A longitudinal brain imaging study. Neuropsychopharmacology 35: 1743-1750, 2010
39. Petrini M, Azzarà A: Lithium in the treatment of neutropenia. Curr Opin Hematol 19: 52-57, 2012
40. Gallicchio VS, Chen MG: Influence of lithium on proliferation of hematopoietic stem cells. Exp Hematol 9: 804-810, 1981 (Pubitemid 11051848)
41. Luo J: Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett 273: 194-200, 2009
42. Leis H, Segrelles C, Ruiz S, Santos M, Paramio JM: Expression, localization, and activity of glycogen synthase kinase 3beta during mouse skin tumorigenesis. Mol Carcinog 35: 180-185, 2002 (Pubitemid 36056712)
43. Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD, Seldin DC: Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Res 65: 5792-5801, 2005 (Pubitemid 40911183)
44. Cao Q, Lu X, Feng YJ: Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells. Cell Res 16: 671-677, 2006 (Pubitemid 44091443)
45. Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, Ooi A, Kawakami K, Minamoto T: Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci 98: 1388-1393, 2007 (Pubitemid 47241761)
46. Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD: Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res 65: 2076-2081, 2005 (Pubitemid 40490111)
47. Lyman GH, Williams CC, Preston D, Goldman A, Dinwoodie WR, Saba H, Hartmann R, Jensen R, Shukovsky L: Lithium carbonate in patients with small cell lung cancer receiving combination chemotherapy. Am J Med 70: 1222-1229, 1981 (Pubitemid 11072116)
48. Stein RS, Flexner JM, Graber SE: Lithium and granulocytopenia during induction therapy of acutemyelogenous leukemia. Blood 54: 636-641, 1979 (Pubitemid 10227862)
49. Kelly KJ, Plotkin Z, Dagher PC: Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. J Clin Invest 108: 1291-1298, 2001 (Pubitemid 33107756)
50. Keppler A, Gretz N, Schmidt R, Kloetzer HM, Groene HJ, Lelongt B, Meyer M, Sadick M, Pill J: Plasma creatinine determination in mice and rats: An enzymatic method compares favorably with a high-performance liquid chromatography assay. Kidney Int 71: 74-78, 2007 (Pubitemid 44967737)
51. Gong R, Rifai A, Ge Y, Chen S, Dworkin LD: Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in renal tubular epithelial cells. J Biol Chem 283: 7401-7410, 2008
52. Gong R, Rifai A, Dworkin LD: Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: Targeting the inflamed vascular endothelium. J Am Soc Nephrol 17: 2464-2473, 2006 (Pubitemid 44300962)